Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis

NARecruitingINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
AL Amyloidosis
Interventions
DRUG

[18F]Florbetaben

"Patients will undergo on the same day:~* 18F-florbetaben PET-CT scans. The dose to be injected intravenously (6 second/mL) will be 370 MBq (for a 70 Kg patient);~* standard assessment of clonal and organ disease;~* echocardiography;~* cardiac magnetic resonance.~All the patients will undergo those evaluations at baseline and 6 months after treatment initiation."

Trial Locations (1)

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER